Progression of sleep disorders spectrum in Parkinson’s Disease: A 5 year clinical longitudinal study
Objective: To investigate longitudinal changes in the prevalence of different sleep disorders in the PPMI cohort of patients with Parkinson’s Disease (PD). Background: Sleep disturbances…Prodromal features of Parkinson’s disease in women
Objective: To identify how prodromal features interact to determine Parkinson’s disease (PD) risk in women. Background: The neuronal loss that leads to PD progresses insidiously…The prevalence and associated features of REM sleep without atonia
Objective: 1. To determine the prevalence of idiopathic and secondary REM sleep without atonia (RSWA). 2. To assess excessive daytime sleepiness and depressive symptoms in…Relationship between sleep profiles and clinical features in Parkinson’s disease
Objective: To document the prevalence of sleep disturbance and excessive daytime sleepiness (EDS) in Taiwanese Parkinson’s disease (PD) patients and to identify the risk factors…Excessive daytime sleepiness in Parkinson’s disease: risk factors and clinical associations
Objective: To examine the frequency and risk factors of excessive daytime sleepiness (EDS) in patients with PD and to determine relationships between EDS and another…Somnolence as untoward stimulation effect in subthalamic deep brain stimulation (STN DBS) for Parkinson’s disease (PD)
Objective: Excessive daytime sleepiness is a relatively common feature in PD. However, it has not been reported as a side effect of STN DBS. We…Istradefylline improves not only motor symptoms but also sleep disturbance, daytime sleepiness, and QOL of Parkinson’s disease patients.
Objective: This study analyzed the clinical effectiveness of istradefylline in terms of sleep disturbance in Parkinson’s disease (PD) patients. Background: A selective adenosine A2A receptor…The role of phosphodiesterase 4 in sleep disturbances in Parkinson’s disease
Objective: We aimed to assess the association between phosphodiesterase 4 (PDE4) expression and sleep disturbances in vivo using combined multimodal magnetic resonance imaging (MRI) and…J-FIRST: First-in-Japan observational study of Parkinson’s disease treatments and nonmotor symptoms
Objective: To clarify the clinical manifestations of nonmotor symptoms (NMSs) and identify factors affecting NMSs and quality of life (QOL) in Japanese patients with Parkinson's…Longitudinal assessment of sleep in an incident Parkinson’s disease cohort
Objective: To evaluate subjective and objective measures of sleep disturbance in an incident PD cohort over longitudinal follow-up. Background: Sleep disturbance is widely recognised as…
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- Next Page »